Best Momentum Stocks to Buy for September 17th
MSGM, ASMB and MTG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 17th, 2026.
Zacks Investment Research9/17/2026Positive
ASMB
Assembly Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$481.73M
P/E Ratio
19.08
EPS
$1.24
Beta
1.13
52W High
$39.71
52W Low
$21.80
50-Day MA
$29.24
200-Day MA
$28.79
Dividend Yield
—
Profit Margin
-0.06%
Forward P/E
500.00
PEG Ratio
0.00
About Assembly Biosciences Inc
Assembly Biosciences, Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $74.84M |
| Gross Profit (TTM) | $11.19M |
| EBITDA | $-8.69M |
| Operating Margin | -47.40% |
| Return on Equity | -0.03% |
| Return on Assets | -2.67% |
| Revenue/Share (TTM) | $4.57 |
| Book Value | $15.40 |
| Price-to-Book | 1.70 |
| Price-to-Sales (TTM) | 6.44 |
| EV/Revenue | 2.683 |
| EV/EBITDA | 0.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 38.90% |
| Shares Outstanding | $20.36M |
| Float | $9.17M |
| % Insiders | 27.66% |
| % Institutions | 69.50% |
Historical Volatility
HV 10-Day
55.99%
HV 20-Day
59.42%
HV 30-Day
71.66%
HV 60-Day
63.07%
HV Rank
94.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($52.00 target)
4
BuyLatest News
New Strong Buy Stocks for September 17th
MOV, MAX, MTG, ASMB and MSGM have been added to the Zacks Rank #1 (Strong Buy) List on September 17th, 2026.
Zacks Investment Research9/17/2026Positive
Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced senior management will present during the H.C. Wainwright & Co. 28th Annual Global Investment Conference at 8:30 a.m. Eastern Time on September 16, 2026.
GlobeNewsWire9/10/2026Neutral
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks
COCO, CHEF, ASMB and CDNA stand out as four defensive picks amid volatility induced by rising oil prices and Middle East tensions.
Zacks Investment Research9/9/2026Neutral
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
– Assembly Bio to share 40% of U.S. development costs and profits for helicase-primase inhibitor program for recurrent genital herpes –
GlobeNewsWire9/8/2026Neutral
Wall Street Analysts See a 35.71% Upside in Assembly Biosciences (ASMB): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 35.7% in Assembly Biosciences (ASMB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks Investment Research9/7/2026Positive
Should You Buy Assembly Biosciences (ASMB) After Golden Cross?
Assembly Biosciences, Inc. (ASMB) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ASMB's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Zacks Investment Research9/4/2026Positive
5 Stocks With Recent Price Strength Buoyed by a Strong August
EDRY, RCMT, ASMB, DCTH and NESR show strong recent price momentum after a strong August, backed by improving earnings expectations.
Zacks Investment Research9/4/2026Positive
Here's Why Momentum in Assembly Biosciences (ASMB) Should Keep going
Assembly Biosciences (ASMB) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Zacks Investment Research9/3/2026Positive
Best Momentum Stocks to Buy for August 25th
LQDT, IA and ASMB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 25th, 2026.
Zacks Investment Research8/25/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ASMB and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/26/2026